An Overview of Safety and Efficacy Between Hypoxia-Inducible Factor-Prolyl-Hydroxylase Inhibitors and Erythropoietin-Stimulating Agents in Treating Anemia in Chronic Kidney Disease Patients

Anemia is one of the common complications in chronic kidney disease (CKD) patients. Erythropoietin and iron deficiencies are the major causes to develop anemia in CKD patients. Untreated anemia is associated with increased morbidity and mortality. Erythropoietin-stimulating agents (ESA) with iron su...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonia, Shamsun Nahar, George, Sherie, Shahi, Srushti R, Ali, Zahra, Abaza, Abdelrahman, Jamil, Aneeque, Gutlapalli, Sai Dheeraj, Ali, Marya, Oble, Mrinal J P, Yu, Ann Kashmer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436024/
https://www.ncbi.nlm.nih.gov/pubmed/37602095
http://dx.doi.org/10.7759/cureus.42045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436024/
https://www.ncbi.nlm.nih.gov/pubmed/37602095
http://dx.doi.org/10.7759/cureus.42045

Ejemplares similares